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Introduction: Urinary tract infection (UTI) is the most common serious bacterial infection 
during infancy. The aim of the present study was to evaluate demographic characteristics, 
clinical presentations and findings, and antimicrobial resistance among infants and children 
hospitalized in Tabriz Children’s Hospital, Tabriz, Iran.
Methods: In this descriptive observational study, 100 children who had been admitted with 
UTI diagnosis to Tabriz Children’s Hospital from March 2003 to March 2008 were studied. 
Demographic characteristics, chief complaints, clinical presentations and findings, urine analysis 
and cultures, antimicrobial resistance, and sonographic and voiding cystourethrographic reports 
were evaluated.
Results: The mean age of patients was 35.77 ± 39.86 months. The male to female ratio was 
0.26. The mean white blood cell count was 12,900 ± 5226/mm3. Sixty-two percent of patients 
had leukocytosis. The most common isolated pathogen was Escherichia coli spp (77%) followed 
by Klebsiella spp (10%), Enterobacter spp (9%), and Enterococcus spp (4%). Isolated pathogens 
were highly resistant to ampicillin, cotrimoxazole, and cephalexin (71%–96%), intermediate 
sensitivity to third-generation cephalosporins, and highly sensitive to ciprofloxacin (84.4%), 
amikacin (83.8%), and nitrofurantoin (82.8%).
Conclusion: The most common pathogen of UTI in the hospitalized children was E. coli spp. 
The isolated pathogens were extremely resistant to ampicillin, and highly sensitive to cipro-
floxacin and amikacin.
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Introduction
Urinary tract infection (UTI) is the most common serious bacterial infection during 
infancy,1 and many children with UTI are admitted to hospital.2 UTI has been con-
sidered an important risk factor for the development of progressive renal disease and 
long-term complications.3
UTI mostly occurs during the first year of life in boys, much more commonly in 
uncircumcised boys. The prevalence of UTI varies with the age. During the first year 
of life, the male to female ratio range is 2.8–5.4. Beyond 1–2 years, there is a striking 
female preponderance with a 1:10 male to female ratio.4
Escherichia coli spp corresponds with 75%–90% of all UTIs, followed by   Klebsiella 
spp and Proteus spp species in females, but previous reports have showed that Proteus 
spp is as common as E. coli in UTIs of males aged .1 year. Others report a prepon-
derance of Gram-positive organisms in UTIs of males. Staphylococcus saprophyticus 
and Enterococcus spp are UTI causative pathogens in both sexes.4
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Most of these children receive empirical antibiotic therapy 
before revealing the causative pathogen and antimicrobial 
sensitivity and resistance.1 Recently, Farrell et al5 demonstrated 
extremely high resistance to trimethoprim, ampicillin, and 
cephalosporins, rendering them unsuitable for empirical use. 
Increasing resistance of bacterial pathogens is of worldwide 
concern that is varied in different regions and even countries.1,5 
Such reports show that continued surveillance and investiga-
tion of other oral agents for treatment of UTI in the community 
is required.4 A recent study by Mortazavi and Shahin6 in the 
Azerbaijan region showed that the prevalence of bacterial 
cause of UTI and resistance to antibacterial regimes changed 
from 2000 to 2007. So, the present study aimed to evalu-
ate demographic characteristics, clinical presentations and 
  findings, and especially antimicrobial resistance among 
infants and children hospitalized due to UTI in northwest Iran’s 
  referral center, Tabriz Children’s Hospital, Tabriz, Iran.
Materials and methods
Study design and population
The present descriptive observational study was carried out in 
the infectious disease ward of Tabriz Children’s Hospital. From 
March 2003 to March 2008, 230 patients were hospitalized 
with a principal diagnosis of UTI. Hospital records for these 
children were studied and finally the complete data of 100 
patients were collected. Age (months for patients aged ,2 
years and years for patients aged .2 years), gender, weight, 
history of previous hospitalization, chief complaint, clinical 
presentation, body temperature, duration of hospitaliza-
tion, outcome, white blood cell (WBC) count, erythrocytes 
sedimentation rate (ESR), C-reactive protein (CRP), urine 
analysis and culture, empirically used antibiotics, antibiotic 
resistance and sensitivity, sonography, and voiding cystoure-
thrography were extracted.
All participants signed informed written consent and the 
study protocol was approved by the Ethics Committee of 
Tabriz University of Medical Sciences, which was in compli-
ance with the Helsinki declaration.
Sample collection and tests performed
The inclusion criteria were diagnosis of UTI and availability 
of complete documentation. Change in diagnosis, presence 
of genitourinary abnormalities (except vesicoureteral reflux 
[VUR]), and loss of any study variables were considered 
criteria for exclusion.
Urine samples were collected by suprapubic aspiration 
in neonates, urine bag (using sterile method) in infants 
aged 1 month to 2.5 years, and midstream urine in children 
aged .2.5 years. Diagnosis of UTI was defined as any 
  colony-forming units/mL of a single organism on a suprapubic 
aspiration method, or $105 colony-forming units/mL on a 
clean-catch specimen of freshly voided urine using urine 
bag and midstream methods. Urine culture, antimicrobial 
susceptibility tests, and interpretation were done using 
Clinical and Laboratory Standards Institute guidelines.7 These 
samples were processed on blood agar and MacConkey agar 
medium (HiMedia Laboratories Pvt Ltd, Mumbai, India) with 
a standard loop and then were incubated at 37°C overnight. 
  Antimicrobial susceptibility and resistance testing was 
performed by the disk diffusion method on cultures using 
antibiotic disks (PADTAN TEB antimicrobial susceptibility 
test disks; Padtan-Teb Co, Tehran, Iran). All laboratory tests 
were done in the laboratory of Tabriz Children’s Hospital.
Leukocytosis was defined according to the age of patients.8 
Presence of more than five WBCs in one light microscopic 
field was considered as active urine   analysis.9 CRP was 
determined using an ENISON CRP latex commercial kit 
  (Enison Lab and Pharmaceutical Industries, Tehran, Iran). 
  Cutoff values for CRP were +1 for 10–25 mg/L, +2 for 
25–50 mg/L, and +3 for .50 mg/L.
Statistical analysis
Statistical analysis was performed using the SPSS (v 13.0; 
SPSS Inc, Chicago, IL) software package. Quantitative data 
are presented as mean ± standard deviation, while qualitative 
data are demonstrated as frequency and percent. The statistical 
tests for comparison were chi-square test, independent sample 
t-test, and one-way analysis of variance test. A P-value of less 
than 0.05 was considered statistically significant.
Results
Data from 100 patients were completely extracted and 
analyzed. The mean age of infants (,2 years) was 
9.39 ± 5.89 months, and the mean age of children ($2 years) 
was 6.30 ± 3.01 years. Twenty-one patients were male 
(21%) and 79 were female (79%). Male to female ratio in all 
patients, in patients aged ,1 year, aged between 1 and 2 years, 
and .2 years were 21:79, 12:32, 4:12, and 5:35, respectively. 
Thirty-eight patients had positive history of   hospitalization; 
24 were hospitalized for the first time (24%), four for the 
second time (4%), three for the third time (3%), five for the 
fourth time (5%), and two for the fifth time (2%).
The mean body weight of studied patients was 
11.79 ± 7.53 kg (range 2.10–41.00 kg). Duration of 
  hospitalization was 7.89 ± 4.36 days (range 2–23 days). The 
frequency of chief complaints is listed in Table 1.
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The mean body temperature at time of admission 
was 37.84°C ± 0.97°C (range 36°C–41.5°C). Forty-two 
  percent of patients had fever. Mean body temperature for 
patients with and without fever was 38.94°C ± 0.60°C and 
37.27°C ± 0.55°C, respectively (P = 0.002).
The mean WBC count was 12,900 ± 5226/mm3 (range 
4300–28,500/mm3). Sixty-two percent of patients had 
  leukocytosis. CRP was negative in 55 patients (55%); +1 in 
17 patients (17%), +2 in 21 patients (21%), +3 in six patients 
(6%), and +4 in one patient (1%). The mean first-hour ESR 
level was 38.74 ± 30.82 mm/hour (range 2–120 mm/hour).
Ninety-two patients (92%) had active urine analysis 
(more than five WBC per field). More than five red blood 
cells per field were reported for 15 patients (15%). The most 
common isolated pathogen was E. coli (77%), followed 
by Klebsiella spp (10%), Enterobacter spp (9%), and 
  Enterococcus spp (4%).
Antibiotic resistances are shown in Table 2. Sonographic 
findings were normal in 66 patients (66%). Abnormal findings 
were unilateral in 25 patients and bilateral in five patients. 
Increased thickness of bladder wall and ascites were reported 
in two patients each. Sonographic findings are shown in 
Table 3.
Forty-two patients underwent cystourethrography   during 
hospitalization (42%). Thirteen patients were advised to 
complete it as outpatients (13%), but 45 did not undergo 
cystourethrography (45%). Of 42 patients, 18 had normal 
findings (43%). Fourteen patients had VUR (14%) and nine 
patients had bilateral VUR (9%). Neurogenic bladder was 
reported in one patient (1%). Cystourethrographic findings 
are listed in Table 4.
Table 5 shows the comparison of demographic,   clinical, 
and laboratory findings according to cause of UTI. As 
  demonstrated, there was no significant difference between 
causes of UTI in the case of male to female ratio, infant to 
child ratio, age, weight, body temperature, fever, WBC, leu-
kocytosis, first-hour ESR, and duration of hospitalization.
Discussion
UTI is recognized increasingly as a common cause of fever 
in young children.10–12 However, clinical findings indicating 
UTI in this group of patients are often subtle and nonspecific, 
with fever often being the only finding.13 During the present 
study, fever was recognized as the most common unspecific 
symptom of UTI.
Clinical UTI is characterized by any or all of the   following: 
abdominal or flank pain, fever, malaise, nausea, vomiting, 
and, occasionally, diarrhea. Newborns may show nonspecific 
symptoms such as poor feeding, irritability, and weight loss.4 
Table 1 Frequency of chief complaint at time of referring to 
hospital
Symptoms Percent
Fever 36
Dysuria 30
Crying at time of urination 14
Failure to thrive 12
Diarrhea 9
Anorexia 7
Flank pain 7
Frequency 6
Vomiting 3
Hematuria 3
Malodorous urine 3
Poor feeding 3
Abdominal pain 3
Table 2 Antibiotic resistance of isolated pathogens
Antibiotic Resistance (%)
Escherichia coli Klebsiella spp Enterobacter spp Enterococcus spp
Ampicillin 94.7 100 100 100
Cotrimoxazole 71.1 90 66.7 75
Cephalexin 68.4 80 77.8 –
Gentamicin 36.1 60 37.5 100
Nalidixic acid 33.3 40 22.2 75
Ceftazidime 27.6 75 0 –
Ceftizoxime 26.3 60 22.2 –
Ceftriaxone 22.4 60 33.3 –
Cefotaxime 22.7 50 22.2 –
Cefixime 22.4 50 22.2 –
Vancomycin – – – 0
Nitrofurantoin 14.5 40 11.1 25
Amikacin 11.8 10 22.2 –
Ciprofloxacin 14.5 10 0 75
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Table 4 Frequency of cystourethrographic findings
Right kidney 
N (%)
Left kidney 
N (%)
P*
Reflux Grade I 2 (2) 3 (3) NS
Grade II 2 (2) 2 (2) NS
Grade III 8 (8) 7 (7) NS
Grade IV 3 (3) 2 (2) NS
Grade V 2 (2) 0 (0) NS
Note: *Chi-square test was used.
Abbreviation: NS, not significant.
Table 3 Frequency of sonographic findings
Right kidney 
N (%)
Left kidney 
N (%)
P*
Hydronephrosis 12 (12) 13 (13) NS
Atrophy and hydronephrosis 1 (1) 1 (1) NS
Hypoplasia 1 (1) 2 (2) NS
Renal stones 3 (3) 3 (3) NS
Ureteral occlusion 0 (0) 1 (1) NS
Note: *Chi-square test was used.
Abbreviation: NS, not significant.
In the present study, UTI clinically presented most commonly 
with fever followed by dysuria, crying at time of urination, 
failure to thrive, diarrhea, anorexia, flank pain, and frequency. 
Abdominal or flank pain and nausea/vomiting were not as 
frequent as reported before.4 Also, dysuria and diarrhea 
were among the common clinical presentations of UTI in 
this study.
Demographic findings were consistent with previous 
studies.2–4,13–15 The proportion of UTI in females was higher 
than in males after the first year of life. The male to female 
ratio during the first year of life has previously been reported 
as 2.8–5.4:1, while the results of the present study had a 
lower ratio. Striking female preponderance with a male to 
female ratio of 1:10 has been reported in patients with UTI 
aged beyond 1–2 years.4 Such findings have been reported 
in the present study.
VUR caused by retrograde urine flow from the bladder 
to the kidneys can culminate in recurrent UTI, severe renal 
complications, and end stage renal failure.15–18 As kidney 
damage resulting from severe VUR is preventable, early 
detection, follow-up, and proper management of underlying 
lower urinary tract abnormalities are desirable.19,20 In the 
present study, VUR has been revealed in 31 kidney-ureter 
units as the risk factor of UTI (31%).
In the present study, E. coli was isolated from 77% 
of patients as the common pathogen of UTI, similar to 
Mathai et al’s21 study findings. The emergence of resistant 
bacteria is a significant problem in UTI chemotherapy. In 
Japan,   isolation of fluoroquinolone-resistant E. coli from 
patients with UTI is reported as a serious therapeutic   problem.22 
In the   present study, E. coli showed 88.3%, 67.5%, and 57.1% 
  resistance to ampicillin, cotrimoxazole, and cephalexin, 
respectively. In most studies in Canada, Europe, Africa, 
Turkey, Spain, Taiwan, and Israel, the majority of isolated 
pathogens were resistant to ampicillin and cotrimoxazole.23–25 
The present study results showed that the best activity against 
E. coli was achieved with amikacin, nitrofurantoin, and cipro-
floxacin, followed by third-generation cephalosporins. These 
results are consistent with Yuksel et al23 and Turnidge et al.25
Klebsiella spp had a varying antibiotic resistance and 
showed higher resistance to ampicillin (100%), cotrimox-
azole (90%), and cephalexin (80%). Also, Klebsiella spp 
had intermediate resistance against ceftriaxone (60%), 
cefotaxime (50%), and cefixime (50%), and showed   lowest 
resistance to amikacin (10%) and ciprofloxacin (10%). 
Yuksel et al24 reported a low rate of resistance of Klebsiella 
spp against amikacin (50%) and ciprofloxacin (50%), 
and a higher level of resistance against ampicillin (82%). 
  Sensitivity of Klebsiella spp to cotrimoxazole in the   present 
study was 10%, while other studies reported 65%–75% 
sensitivity to this antibiotic22,24 due to uncontrolled admin-
istration of the drug.
Enterobacter spp has the lowest prevalence as a UTI 
pathogen.23 In the present study, the prevalence of this Gram-
negative bacteria is reported at about 9%, with excessive 
resistance to ampicillin (100%), higher resistance to first-
generation cephalosporins (cephalexin), and mild resistance 
to third-generation cephalosporins, consistent with Tunidge 
et al’s25 and Catal et al’s26 results. Resistance by the extended 
spectrum betalactamase (ESBL) mechanism is an important 
emerging problem in Enterobacter spp.27,28 ESBLs are beta-
lactamase that hydrolyze penicillin and extended spectrum 
cephalosporins with an oxyimino side chain that includes cef-
tazidime, ceftriaxone, cefotaxime, and aztreonam.   Antibiotic 
utilization patterns, including widespread cephalosporin 
use, have been associated with the emergence of ESBLs 
and a decrease of administration of these antibiotics has 
been associated with control of ESBL emergence.29,30 The 
antibiotic resistance rate of Enterobacter spp to ciprofloxacin 
is low in children, due to the rarity of its administration. In 
contrast to Caksen et al’s31 findings, unfortunately, 100% of 
isolated Enterobacter spp were resistant to ciprofloxacin in 
the present study.
In this study, 4% of UTI pathogens were Enterococcus spp; 
its prevalence was similar to Muratani and Matsumoto’s 22 report. 
Findings in this study showed that isolated Enterococcus spp 
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were extremely (100%) resistant to ampicillin and   gentamicin. 
Such high resistance to these antibiotics has been reported 
previously by other authors.31 Sensitivity of Enterococcus 
spp to vancomycin and nitrofurantoin was 100% and 75%, 
respectively, which was consistent with Mathai et al’s21 and 
Turnidge et al’s25 findings.
Comparing the present study with a recent study by 
Mortazavi and Shahin6 in East Azerbaijan, demographic 
characteristics and prevalence of bacterial causes of UTI 
did not change. Comparing the antibacterial resistance 
of E. coli to Mortazavi and Shahin’s study, resistance to 
ampicillin increased and resistance to gentamicin, nalidixic 
acid, ceftazidime, and cefixime decreased but remained 
unchanged against other antibiotics. Also, Klebsiella spp 
showed increased antibacterial resistance against nalidixic 
acid, cefixime, and cotrimoxazole, and decreased resistance 
to amikacin and nitrofurantoin.
Finally, the present study was a small, regional retro-
spective study and results show that there is a need for 
large longitudinal national studies to determine prevalence, 
demographic characteristics, possible etiology, and antibiotic 
resistance. The present study has also evaluated the pattern 
of antibiotic resistance among hospitalized children with 
diagnosis of UTI, which provides important information 
concerning this region.
Conclusion
E. coli is the most common isolated bacterium in hospitalized 
children with a principal diagnosis of UTI. Most of the isolated 
pathogens are highly resistant to ampicillin, cotrimoxazole, and 
cephalexin (71%–96%), have intermediate sensitivity to third-
generation cephalosporins, and high sensitivity to ciprofloxacin 
(84.4%), amikacin (83.8%), and nitrofurantoin (82.8%).
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